Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 207

Работа: Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling

  1. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

    Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht +9

    Статья2012Цитирований: 8
    ABI
  2. Inflammation and immune dysfunction in Parkinson disease

    Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser +3

    Обзорная статья2022Цитирований: 5
    ABI
  3. Regulatory roles of three miRNAs on allergen mRNA expression in <i>Tyrophagus putrescentiae</i>

    Ying Zhou, Qingqing Li, Ruilin Pan +6

    Статья2021Цитирований: 3
    ABI
  4. Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis

    Kaijun Wang, Jie Yin, Jiayi Chen +3

    Статья2024Цитирований: 3
    ABI
  5. Complex I and Parkinson's Disease

    J. Timothy Greenamyre, Todd Sherer, Ranjita Betarbet +1

    Обзорная статья2001Цитирований: 2
    ABI
  6. Mitochondrial dysfunction in Parkinson's disease

    Anindita Bose, M. Flint Beal

    Обзорная статья2016Цитирований: 2
    ABI
  7. Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay

    Padmashri Naren, Anjali Cholkar, Suchita N. Kamble +7

    Обзорная статья2022Цитирований: 2
    ABI
  8. Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease

    Kai-Jung Lin, Shang‐Der Chen, Kai-Lieh Lin +8

    Обзорная статья2022Цитирований: 2
    ABI
  9. What causes the death of dopaminergic neurons in Parkinson’s disease?

    D. James Surmeier, Jaime N. Guzmán, Javier Sánchez-Padilla +1

    Статья2010Цитирований: 2
    ABI
  10. Neuroinflammation in Parkinson’s disease and its potential as therapeutic target

    Qinqin Wang, Yingjun Liu, Jiawei Zhou

    Обзорная статья2015Цитирований: 2
    ABI
  11. Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges

    Marta Arenas‐Jal, Josep M. Suñé‐Negre, Encarna García‐Montoya

    Обзорная статья2020Цитирований: 2
    ABI
  12. Mitochondrial Mechanisms of Neural Cell Death and Neuroprotective Interventions in Parkinson's Disease

    Gary Fiskum, Anatoly A. Starkov, Brian M. Polster +1

    Обзорная статья2003Цитирований: 2
    ABI
  13. Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond

    Céline Perier, Jordi Bové, Miquel Vila

    Обзорная статья2011Цитирований: 2
    ABI
  14. Occupational and environmental risk factors for Parkinson's disease

    Beryen Lai, S.A Marion, Kay Teschke +1

    Обзорная статья2002Цитирований: 2
    ABI
  15. Parkinson's disease: from monogenic forms to genetic susceptibility factors

    Suzanne Lesage, Alexis Brice

    Обзорная статья2009Цитирований: 2
    ABI
  16. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

    Brent R. Stockwell, José Pedro Friedmann Angeli, Hülya Bayır +24

    Обзорная статья2017Цитирований: 2
    ABI
  17. Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder

    Asmat Ullah Khan, Muhammad Akram, Muhammad Daniyal +1

    Обзорная статья2018Цитирований: 2
    ABI
  18. Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials

    Abolfazl Akbari, Gholam Reza Mobini, Shahram Agah +7

    Обзорная статья2020Цитирований: 2
    ABI
  19. Ferroptosis in Parkinson’s disease: glia–neuron crosstalk

    Zhangli Wang, Lin Yuan, Wen Li +1

    Обзорная статья2022Цитирований: 2
    ABI